DavosPharma’s corporate offering covers all the non-clinical activities required to get a drug from conception to commercialization. DavosPharma provides discovery chemistry & biology, pre-clinical development, DMPK, toxicology and all required CMC activities including custom synthesis of organic molecules, dosage form development, and manufacturing of cGMP intermediates, APIs, and drug product.


Matt Cwiklinski Director, Business Development Phone: 201-995-0070
Tony DelPrete Executive Vice President and CFO Phone: 201-995-0070
555 Saturn Blvd. Ste B-420 San Diego, CA 92154 USA